Identification of the novel HLA-B allele, HLA-B*15:539, in a South-Sudanese individual.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
10 2019
Historique:
received: 28 06 2019
revised: 01 07 2019
accepted: 01 07 2019
pubmed: 5 7 2019
medline: 9 7 2020
entrez: 5 7 2019
Statut: ppublish

Résumé

HLA-B*15:539 differs from HLA-B*15:151 by two nucleotide substitutions.

Identifiants

pubmed: 31271260
doi: 10.1111/tan.13624
doi:

Substances chimiques

HLA-B15 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

380-381

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Halliwell JA, Hayhurst JH, Flicek P, Parham P, Marsh SGE. The IPD and IPD-IMGT/HLA Database: allele variant databases. Nucleic Acids Res. 2015;43:D423-D431.
Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Gil Benedek (G)

Tissue Typing and Immunogenetics Laboratory, Hadassah Hebrew University Hospital, Jerusalem, 91120, Israel.

Mahmoud Abed El-Latif (M)

Tissue Typing and Immunogenetics Laboratory, Hadassah Hebrew University Hospital, Jerusalem, 91120, Israel.

Keren Miller (K)

Tissue Typing and Immunogenetics Laboratory, Hadassah Hebrew University Hospital, Jerusalem, 91120, Israel.

Eithan Galun (E)

Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Hospital, Jerusalem, 91120, Israel.

Mia Levite (M)

Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Hospital, Jerusalem, 91120, Israel.
School of Pharmacy, Faculty of Medicine, The Hebrew University, Jerusalem, 12065, Israel.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH